{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:14:53Z","timestamp":1785946493910,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12253-020-00829-9","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T22:07:08Z","timestamp":1590790028000},"page":"2067-2073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Antonio","family":"Travaglino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-2333","authenticated-orcid":false,"given":"Antonio","family":"Raffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Gencarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Insabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"issue":"1","key":"829_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5\u201329","journal-title":"CA Cancer J Clin"},{"key":"829_CR2","doi-asserted-by":"crossref","unstructured":"Raffone A, Travaglino A, Mascolo M, Carbone L, Guida M, Insabato L, Zullo F (2019) TCGA molecular groups of endometrial cancer: pooled data about prognosis. Gynecol Oncol 155(2):374\u2013383","DOI":"10.1016\/j.ygyno.2019.08.019"},{"issue":"5","key":"829_CR3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/aqy178","volume":"151","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, de Luca C, Mollo A, Mascolo M, de Placido G, Insabato L, Zullo F (2019) Immunohistochemical nuclear expression of \u03b2-catenin as a surrogate of CTNNB1 exon 3 mutation in endometrial Cancer. Am J Clin Pathol 151(5):529\u2013538","journal-title":"Am J Clin Pathol"},{"key":"829_CR4","doi-asserted-by":"publisher","unstructured":"Raffone A, Travaglino A, Santoro A, Esposito I, Angelico G, Spadola S, Zannoni GF (2019) Accuracy of one-step nucleic acid amplification in detecting lymph node metastases in endometrial cancer. Pathol Oncol Res. https:\/\/doi.org\/10.1007\/s12253-019-00727-9","DOI":"10.1007\/s12253-019-00727-9"},{"key":"829_CR5","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/aogs.13587","volume":"98","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2019) Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand 98:1086\u20131099. https:\/\/doi.org\/10.1111\/aogs.13587","journal-title":"Acta Obstet Gynecol Scand"},{"key":"829_CR6","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) \u2013 Uterine neoplasms. Version 3.2019 \u2013 February 11, 2019"},{"key":"829_CR7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e31828c63ed","volume":"37","author":"LN Hoang","year":"2013","unstructured":"Hoang LN, McConechy MK, Kobel M et al (2013) Histotype-genotype correlation in 36 high-grade endometrial carcinomas. Am J Surg Pathol 37:1421\u20131432","journal-title":"Am J Surg Pathol"},{"key":"829_CR8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","volume":"37","author":"CB Gilks","year":"2013","unstructured":"Gilks CB, Oliva E, Soslow RA (2013) Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol 37:874\u2013881","journal-title":"Am J Surg Pathol"},{"issue":"7447","key":"829_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network et al (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67\u201373","journal-title":"Nature"},{"issue":"2","key":"829_CR10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S et al (2015) A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer 113(2):299\u2013310","journal-title":"Br J Cancer"},{"issue":"5","key":"829_CR11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","volume":"123","author":"A Talhouk","year":"2017","unstructured":"Talhouk A, McConechy MK, Leung S et al (2017) Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer. Cancer 123(5):802\u2013813","journal-title":"Cancer"},{"issue":"5","key":"829_CR12","first-page":"1180","volume":"29","author":"S Kommoss","year":"2018","unstructured":"Kommoss S, McConechy MK, Kommoss F et al (2018) Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. AnnOncol 29(5):1180\u20131188","journal-title":"AnnOncol"},{"issue":"16","key":"829_CR13","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","volume":"22","author":"E Stelloo","year":"2016","unstructured":"Stelloo E, Nout RA, Osse EM, J\u00fcrgenliemk-Schulz IJ, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Nijman HW, Putter H, Bosse T, Creutzberg CL, Smit VTHBM (2016) Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin Cancer Res 22(16):4215\u20134224","journal-title":"Clin Cancer Res"},{"issue":"5","key":"829_CR14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","volume":"42","author":"T Bosse","year":"2018","unstructured":"Bosse T, Nout RA, McAlpine JN et al (2018) Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups. Am J Surg Pathol 42(5):561\u2013568","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"829_CR15","first-page":"174","volume":"148","author":"CM Cosgrove","year":"2018","unstructured":"Cosgrove CM, Tritchler DL, Cohn DE et al (2018) An NRG oncology\/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. GynecolOncol 148(1):174\u2013180","journal-title":"GynecolOncol"},{"key":"829_CR16","doi-asserted-by":"crossref","unstructured":"Leskela S, P\u00e9rez-Mies B, Rosa-Rosa JM, Cristobal E, Biscuola M, Palacios-Berraquero ML, Ong S, Matias-Guiu Guia X, Palacios J (2019) Molecular basis of tumor heterogeneity in endometrial carcinosarcoma. Cancers (Basel) 11(7):964","DOI":"10.3390\/cancers11070964"},{"issue":"5","key":"829_CR17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/path.5034","volume":"244","author":"J McAlpine","year":"2018","unstructured":"McAlpine J, Leon-Castillo A, Bosse T (2018) The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 244(5):538\u2013549","journal-title":"J Pathol"},{"key":"829_CR18","doi-asserted-by":"crossref","unstructured":"Raffone A, Travaglino A, Saccone G, Alviggi C, Mascolo M, De Placido G, Insabato L, Mollo A, Zullo F (2019) Management of women with atypical polypoid adenomyoma of the uterus: a quantitative systematic review. Acta Obstet Gynecol Scand 98(7):842\u2013855","DOI":"10.1111\/aogs.13553"},{"key":"829_CR19","doi-asserted-by":"crossref","unstructured":"Raffone A, Travaglino A, Saccone G et al (2019) Should progesterone and estrogens receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis. Acta Obstet Gynecol Scand 98(8):976\u2013987","DOI":"10.1111\/aogs.13586"},{"key":"829_CR20","doi-asserted-by":"crossref","unstructured":"Lionetti R, De Luca M, Travaglino A, Raffone A, Insabato L, Saccone G, Mascolo M, D\u2019armiento M, Zullo F, Corcione F (2019) Treatments and overall survival in patients with Krukenberg tumor. Arch Gynecol Obstet 300(1):15\u201323","DOI":"10.1007\/s00404-019-05167-z"},{"key":"829_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1","journal-title":"Syst Rev"},{"issue":"8","key":"829_CR22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536","journal-title":"Ann Intern Med"},{"issue":"6","key":"829_CR23","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00404-019-05123-x","volume":"299","author":"A Raffone","year":"2019","unstructured":"Raffone A, Travaglino A, Saccone G, Viggiani M, Giampaolino P, Insabato L, Mollo A, de Placido G, Zullo F (2019) PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 299(6):1511\u20131524","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"829_CR24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00404-019-05299-2","volume":"300","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, D\u2019Alessandro P, Arduino B, de Placido G, Mascolo M, Insabato L, Zullo F (2019) Significant risk of occult cancer in complex non-atypical endometrial hyperplasia. Arch Gynecol Obstet 300(5):1147\u20131154","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"829_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/apm.12938","volume":"127","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Mascolo M, Pignatiello S, Mollo A, de Placido G, Insabato L, Zullo F (2019) PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer? APMIS 127(4):161\u2013169","journal-title":"APMIS"},{"key":"829_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/his.13976","volume":"76","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Mascolo M, Guida M, Insabato L, Zannoni GF, Zullo F (2019) Clear cell endometrial carcinoma and the TCGA classification. Histopathology. 76:336\u2013338. https:\/\/doi.org\/10.1111\/his.13976","journal-title":"Histopathology."},{"issue":"5","key":"829_CR27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00404-019-05103-1","volume":"299","author":"A Raffone","year":"2019","unstructured":"Raffone A, Travaglino A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2019) Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis. Arch Gynecol Obstet 299(5):1233\u20131242","journal-title":"Arch Gynecol Obstet"},{"key":"829_CR28","doi-asserted-by":"publisher","unstructured":"Raffone A, Travaglino A, Saccone G, D\u2019Alessandro P, Arduino B, Mascolo M, de Placido G, Insabato L, Zullo F (2019) Diabetes mellitus is associated with occult Cancer in endometrial hyperplasia. Pathol Oncol Res. https:\/\/doi.org\/10.1007\/s12253-019-00684-3","DOI":"10.1007\/s12253-019-00684-3"},{"issue":"5","key":"829_CR29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/his.13776","volume":"74","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Mollo A, de Placido G, Insabato L, Zullo F (2019) Endometrial hyperplasia and risk of coexistent cancer: WHO vs EIN criteria. Histopathology 74(5):676\u2013687","journal-title":"Histopathology"},{"key":"829_CR30","doi-asserted-by":"crossref","unstructured":"Raffone A, Travaglino A, Saccone G, di Maio A, Mollo A, Mascolo M, de Rosa R, de Placido G, Insabato L, Zullo F (2019) Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecol Endocrinol 35(11):932\u2013937","DOI":"10.1080\/09513590.2019.1624716"},{"key":"829_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/apm.12977","volume":"127","author":"A Raffone","year":"2019","unstructured":"Raffone A, Travaglino A, Saccone G, Cieri M, Mascolo M, Mollo A, Insabato L, Zullo F (2019) Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer. APMIS. 127:597\u2013606. https:\/\/doi.org\/10.1111\/apm.12977","journal-title":"APMIS."},{"key":"829_CR32","unstructured":"Travaglino A, Raffone A, Saccone G et al (2019) Congruence between 1994 WHO classification of endometrial hyperplasia and endometrial intraepithelial neoplasia system. Am J Clin Pathol 153(1):40\u201348"},{"key":"829_CR33","doi-asserted-by":"publisher","unstructured":"Travaglino A, Raffone A, Saccone G, Fuggi M, de Placido G, Mascolo M, Mollo A, Insabato L, Zullo F (2019) Immunophenotype of atypical polypoid adenomyoma of the uterus: diagnostic value and insight on pathogenesis. Appl Immunohistochem Mol Morphol. https:\/\/doi.org\/10.1097\/PAI.0000000000000780","DOI":"10.1097\/PAI.0000000000000780"},{"key":"829_CR34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/apm.12988","volume":"127","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G, Mascolo M, D'Alessandro P, Arduino B, Mollo A, Insabato L, Zullo F (2019) Nuclear expression of \u03b2-catenin in endometrial hyperplasia as marker of premalignancy. APMIS. 127:699\u2013709. https:\/\/doi.org\/10.1111\/apm.12988","journal-title":"APMIS."},{"issue":"5","key":"829_CR35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/PGP.0b013e31829ff239","volume":"33","author":"LN Hoang","year":"2014","unstructured":"Hoang LN, Ali RH, Lau S, Gilks CB, Lee CH (2014) Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas. Int J Gynecol Pathol 33(5):483\u2013491","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"829_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/107327481602300111","volume":"23","author":"TN Hembree","year":"2016","unstructured":"Hembree TN, Teer JK, Hakam A, Chiappori AA (2016) Genetic investigation of uterine carcinosarcoma: case report and cohort analysis. Cancer Control 23(1):61\u201366","journal-title":"Cancer Control"},{"issue":"43","key":"829_CR37","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1073\/pnas.1614120113","volume":"113","author":"S Zhao","year":"2016","unstructured":"Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilg\u00fcvar K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP, Santin AD (2016) Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 113(43):12238\u201312243","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"829_CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/PGP.0000000000000346","volume":"36","author":"X Chen","year":"2017","unstructured":"Chen X, Arend R, Hamele-Bena D, Tergas AI, Hawver M, Tong GX, Wright TC, Wright JD (2017) Uterine Carcinosarcomas: clinical, Histopathologic and Immunohistochemical characteristics. Int J Gynecol Pathol 36(5):412\u2013419","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"829_CR39","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/ijc.30537","volume":"140","author":"NL Jones","year":"2017","unstructured":"Jones NL, Xiu J, Chatterjee-Paer S, Buckley de Meritens A, Burke WM, Tergas AI, Wright JD, Hou JY (2017) Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas. Int J Cancer 140(6):1396\u20131404","journal-title":"Int J Cancer"},{"issue":"2","key":"829_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/15384047.2018.1523853","volume":"20","author":"X Lu","year":"2019","unstructured":"Lu X, Zhang L, Zhao H, Chen C, Wang Y, Liu S, Lin X, Wang Y, Zhang Q, Lu T, Yan F (2019) Molecular classification and subtype-specific drug sensitivity research of uterine carcinosarcoma under multi-omics framework. Cancer Biol Ther 20(2):227\u2013235","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"829_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2018.10.032","volume":"152","author":"CW Ashley","year":"2019","unstructured":"Ashley CW, Da Cruz PA, Kumar R et al (2019) Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. Gynecol Oncol 152(1):11\u201319","journal-title":"Gynecol Oncol"},{"issue":"1","key":"829_CR42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-019-02532-w","volume":"475","author":"T Franceschi","year":"2019","unstructured":"Franceschi T, Durieux E, Morel AP, de Saint Hilaire P, Ray-Coquard I, Puisieux A, Devouassoux-Shisheboran M (2019) Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas. Virchows Arch 475(1):85\u201394","journal-title":"Virchows Arch"},{"issue":"2","key":"829_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2018.08.043","volume":"151","author":"Y Liu","year":"2018","unstructured":"Liu Y, Weber Z, San Lucas FA, Deshpande A, Jakubek YA, Sulaiman R, Fagerness M, Flier N, Sulaiman J, Davis CM, Fowler J, Starks D, Rojas-Espaillat L, Lazar AJ, Davies GE, Ehli EA, Scheet P (2018) Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas. Gynecol Oncol 151(2):243\u2013249","journal-title":"Gynecol Oncol"},{"issue":"3","key":"829_CR44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cjp2.18","volume":"1","author":"MK McConechy","year":"2015","unstructured":"McConechy MK, Hoang LN, Chui MH et al (2015) In-depth molecular profiling of the biphasic components of uterine carcinosarcomas. J Pathol Clin Res 1(3):173\u2013185","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"829_CR45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","volume":"31","author":"AD Cherniack","year":"2017","unstructured":"Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Weinstein JN, Zhang J, Akbani R, Levine DA, Akbani R, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bodenheimer T, Bogomolniy F, Boice L, Bootwalla MS, Bowen J, Bowlby R, Broaddus R, Brooks D, Carlsen R, Cherniack AD, Cho J, Chuah E, Chudamani S, Cibulskis K, Cline M, Dao F, David M, Demchok JA, Dhalla N, Dowdy S, Felau I, Ferguson ML, Frazer S, Frick J, Gabriel S, Gastier-Foster JM, Gehlenborg N, Gerken M, Getz G, Gupta M, Haussler D, Hayes DN, Heiman DI, Hess J, Hoadley KA, Hoffmann R, Holt RA, Hoyle AP, Hu X, Huang M, Hutter CM, Jefferys SR, Jones SJM, Jones CD, Kanchi RS, Kandoth C, Kasaian K, Kerr S, Kim J, Lai PH, Laird PW, Lander E, Lawrence MS, Lee D, Leraas KM, Leshchiner I, Levine DA, Lichtenberg TM, Lin P, Ling S, Liu J, Liu W, Liu Y, Lolla L, Lu Y, Ma Y, Maglinte DT, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Mills GB, Moore RA, Mose LE, Mungall AJ, Mungall K, Murray BA, Naresh R, Noble MS, Olvera N, Parker JS, Perou CM, Perou AH, Pihl T, Radenbaugh AJ, Ramirez NC, Rathmell WK, Roach J, Robertson AG, Sadeghi S, Saksena G, Salvesen HB, Schein JE, Schumacher SE, Shen H, Sheth M, Shi Y, Shih J, Simons JV, Sipahimalani P, Skelly T, Sofia HJ, Soloway MG, Soslow RA, Sougnez C, Stewart C, Sun C, Tam A, Tan D, Tarnuzzer R, Thiessen N, Thorne LB, Tse K, Tseng J, van den Berg DJ, Veluvolu U, Verhaak RGW, Voet D, von Bismarck A, Walter V, Wan Y, Wang Z, Wang C, Weinstein JN, Weisenberger DJ, Wilkerson MD, Winterhoff B, Wise L, Wong T, Wu Y, Yang L, Zenklusen JC, Zhang J(J), Zhang H, Zhang W, Zhu JC, Zmuda E, Zuna RE (2017) Integrated molecular characterization of uterine Carcinosarcoma. Cancer Cell 31(3):411\u2013423","journal-title":"Cancer Cell"},{"issue":"1","key":"829_CR46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cncr.30971","volume":"124","author":"M Le Gallo","year":"2018","unstructured":"Le Gallo M, Rudd ML, Urick ME et al (2018) The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas. Cancer 124(1):65\u201373","journal-title":"Cancer"},{"issue":"1","key":"829_CR47","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-019-12985-x","volume":"10","author":"O Gotoh","year":"2019","unstructured":"Gotoh O, Sugiyama Y, Takazawa Y, Kato K, Tanaka N, Omatsu K, Takeshima N, Nomura H, Hasegawa K, Fujiwara K, Taki M, Matsumura N, Noda T, Mori S (2019) Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma. Nat Commun 10(1):4965","journal-title":"Nat Commun"},{"issue":"Suppl 2","key":"829_CR48","first-page":"S75","volume":"99","author":"N Prueksaritanond","year":"2016","unstructured":"Prueksaritanond N, Chantape W (2016) Comparative survival outcomes of uterine papillary serous carcinoma, clear cell carcinoma, grade 3 endometrioid adenocarcinoma, and carcinosarcoma of endometrial cancer in Rajavithi Hospital. J Med Assoc Thail 99(Suppl 2):S75\u2013S83","journal-title":"J Med Assoc Thail"},{"issue":"2","key":"829_CR49","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.3802\/jgo.2016.27.e18","volume":"27","author":"J Zhu","year":"2016","unstructured":"Zhu J, Wen H, Bi R, Wu X (2016) Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study. J Gynecol Oncol 27(2):e18","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"829_CR50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/IGC.0000000000000350","volume":"25","author":"C Zhang","year":"2015","unstructured":"Zhang C, Hu W, Jia N, Li Q, Hua K, Tao X, Wang L, Feng W (2015) Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison. Int J Gynecol Cancer 25(4):629\u2013636","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"829_CR51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.pas.0000171003.72352.9a","volume":"29","author":"B Altrabulsi","year":"2005","unstructured":"Altrabulsi B, Malpica A, Deavers MT, Bodurka DC, Broaddus R, Silva EG (2005) Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 29(10):1316\u20131321","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"829_CR52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/PAI.0000000000000374","volume":"25","author":"O\u00c7 Taskin","year":"2017","unstructured":"Taskin O\u00c7, Onder S, Topuz S et al (2017) A selected immunohistochemical panel aids in differential diagnosis and prognostic stratification of subtypes of high-grade endometrial carcinoma: a clinicopathologic and immunohistochemical study at a single institution. Appl Immunohistochem Mol Morphol 25(10):696\u2013702","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"829_CR53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","volume":"47","author":"CJ Stewart","year":"2015","unstructured":"Stewart CJ, Crook ML (2015) SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma. Pathology 47(5):439\u2013445","journal-title":"Pathology"},{"issue":"12","key":"829_CR54","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2016.156","volume":"29","author":"M Coatham","year":"2016","unstructured":"Coatham M, Li X, Karnezis AN, Hoang LN, Tessier-Cloutier B, Meng B, Soslow RA, Blake Gilks C, Huntsman DG, Stewart CJR, Postovit LM, K\u00f6bel M, Lee CH (2016) Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. Mod Pathol 29(12):1586\u20131593","journal-title":"Mod Pathol"},{"issue":"3","key":"829_CR55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/his.13091","volume":"70","author":"P Ramalingam","year":"2017","unstructured":"Ramalingam P, Croce S, McCluggage WG (2017) Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathology 70(3):359\u2013366","journal-title":"Histopathology"},{"issue":"11","key":"829_CR56","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2016.132","volume":"29","author":"JM Rosa-Rosa","year":"2016","unstructured":"Rosa-Rosa JM, Leskel\u00e4 S, Crist\u00f3bal-Lana E, Sant\u00f3n A, L\u00f3pez-Garc\u00eda M\u00c1, Mu\u00f1oz G, P\u00e9rez-Mies B, Biscuola M, Prat J, Esther OE, Soslow RA, Matias-Guiu X, Palacios J (2016) Molecular genetic heterogeneity in undifferentiated endometrial carcinomas. Mod Pathol 29(11):1390\u20131398","journal-title":"Mod Pathol"},{"issue":"8","key":"829_CR57","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/PAS.0000000000000873","volume":"41","author":"I Espinosa","year":"2017","unstructured":"Espinosa I, Lee CH, D'Angelo E, Palacios J, Prat J (2017) Undifferentiated and dedifferentiated endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis. Am J Surg Pathol 41(8):1121\u20131128","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"829_CR58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","volume":"42","author":"M K\u00f6bel","year":"2018","unstructured":"K\u00f6bel M, Hoang LN, Tessier-Cloutier B, Meng B, Soslow RA, Stewart CJR, Lee CH (2018) Undifferentiated endometrial carcinomas show frequent loss of Core switch\/sucrose nonfermentable complex proteins. Am J Surg Pathol 42(1):76\u201383","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"829_CR59","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","volume":"38","author":"R Murali","year":"2019","unstructured":"Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA (2019) High-grade endometrial carcinomas: morphologic and Immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol 38(Suppl 1):S40\u2013S63","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"829_CR60","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","volume":"28","author":"E Stelloo","year":"2015","unstructured":"Stelloo E, Bosse T, Nout RA, MacKay HJ, Church DN, Nijman HW, Leary A, Edmondson RJ, Powell ME, Crosbie EJ, Kitchener HC, Mileshkin L, Pollock PM, Smit VT, Creutzberg CL (2015) Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Mod Pathol 28(6):836\u2013844","journal-title":"Mod Pathol"},{"issue":"1","key":"829_CR61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2014.05.006","volume":"134","author":"B Meng","year":"2014","unstructured":"Meng B, Hoang LN, McIntyre JB et al (2014) POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Gynecol Oncol 134(1):15\u201319","journal-title":"Gynecol Oncol"},{"key":"829_CR62","doi-asserted-by":"publisher","first-page":"152552","DOI":"10.1016\/j.prp.2019.152552","volume":"22","author":"S Hacking","year":"2019","unstructured":"Hacking S, Jin C, Komforti M, Liang S, Nasim M (2019) MMR deficient undifferentiated\/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications. Pathol Res Pract 22:152552. https:\/\/doi.org\/10.1016\/j.prp.2019.152552","journal-title":"Pathol Res Pract"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-020-00829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-020-00829-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-020-00829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T21:05:41Z","timestamp":1616015141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-020-00829-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1007\/s12253-020-00829-9","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}